Latest issue of Hampshire & IOW Medicines Optimisation Bulletin

The latest bulletin contains information on the following:

1. MHRA drug safety update: Denosumab 60mg (Prolia): should not be used in patients under 18 years due to the risk of serious hypercalcaemia

2. Cardiovascular disease webinars – message from the Primary Care Cardiovascular Disease Optimisation Group

3. SPS: Prescribing available HRT products

4. PSNC: Additional Serious Shortage protocols for HRT now in place

5. Testogel® supply

Download the bulletin here for more information and links:

• https://cpsc.franktesting.co.uk/download_file/view/3557/2483